Traders sold shares of CVS Health Corp (NYSE:CVS) on strength during trading on Wednesday. $87.78 million flowed into the stock on the tick-up and $132.52 million flowed out of the stock on the tick-down, for a money net flow of $44.74 million out of the stock. Of all stocks tracked, CVS Health had the 26th highest net out-flow for the day. CVS Health traded up $0.36 for the day and closed at $66.03
Several brokerages have recently issued reports on CVS. Argus boosted their price target on shares of CVS Health to $100.00 and gave the company a “buy” rating in a report on Tuesday, November 13th. Loop Capital set a $80.00 price target on shares of CVS Health and gave the company a “hold” rating in a report on Wednesday, November 28th. Evercore ISI began coverage on shares of CVS Health in a report on Wednesday, November 28th. They issued an “outperform” rating and a $89.00 price target for the company. Goldman Sachs Group reissued a “neutral” rating and issued a $87.00 price target on shares of CVS Health in a report on Thursday, November 29th. Finally, Cantor Fitzgerald began coverage on shares of CVS Health in a report on Sunday, December 2nd. They issued an “overweight” rating and a $77.84 price target for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $91.44.
The company has a market capitalization of $67.15 billion, a price-to-earnings ratio of 11.19, a price-to-earnings-growth ratio of 0.89 and a beta of 1.03. The company has a current ratio of 2.44, a quick ratio of 1.94 and a debt-to-equity ratio of 1.66.
CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.02. The firm had revenue of $47.27 billion during the quarter, compared to analyst estimates of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The company’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.50 EPS. As a group, equities research analysts predict that CVS Health Corp will post 6.98 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Monday, February 4th. Investors of record on Friday, January 25th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 3.03%. The ex-dividend date of this dividend was Thursday, January 24th. CVS Health’s payout ratio is presently 33.90%.
In other CVS Health news, insider Larry J. Merlo sold 166,368 shares of the business’s stock in a transaction dated Friday, February 1st. The shares were sold at an average price of $64.51, for a total transaction of $10,732,399.68. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Troyen A. Brennan sold 14,229 shares of the business’s stock in a transaction dated Wednesday, November 14th. The stock was sold at an average price of $82.00, for a total transaction of $1,166,778.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 449,763 shares of company stock valued at $30,412,036. Company insiders own 0.53% of the company’s stock.
Large investors have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of CVS Health by 1.7% in the 3rd quarter. Vanguard Group Inc. now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after purchasing an additional 1,445,887 shares during the period. Vanguard Group Inc raised its holdings in shares of CVS Health by 1.7% in the 3rd quarter. Vanguard Group Inc now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after purchasing an additional 1,445,887 shares during the period. BlackRock Inc. raised its holdings in shares of CVS Health by 2.8% in the 3rd quarter. BlackRock Inc. now owns 76,197,017 shares of the pharmacy operator’s stock valued at $5,998,231,000 after purchasing an additional 2,061,915 shares during the period. FMR LLC raised its holdings in shares of CVS Health by 4.3% in the 3rd quarter. FMR LLC now owns 30,069,260 shares of the pharmacy operator’s stock valued at $2,367,052,000 after purchasing an additional 1,250,473 shares during the period. Finally, Oregon Public Employees Retirement Fund raised its holdings in shares of CVS Health by 6,858.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 25,089,377 shares of the pharmacy operator’s stock valued at $383,000 after purchasing an additional 24,728,818 shares during the period. 84.61% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Investors Sell CVS Health (CVS) on Strength (CVS)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2019/02/06/investors-sell-cvs-health-cvs-on-strength-cvs.html.
CVS Health Company Profile (NYSE:CVS)
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Further Reading: What are municipal bonds?
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.